Loading...
Found 938 All Conditions trials
A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Sort by:
- Sort by
- Last updated
To receive genomic data from the GenPath lymphoma panel obtained from tumor samples from previously treated LBCL patients whose tumors have undergone NGS through a PCPD panel Receipt of a GenPath lymphoma panel report N/A
The purpose of this study is to investigate the long-term safety of a type of treatment called CAR T cell therapy. This study focuses on monitoring the long-term risks associated with this therapy, such as delayed adverse events and the persistence of modified T cells in the body.Participants in this …
Investigate the involvement of the microbiome and associated metabolites in ovarian cancer. Generate a predictive model for ovarian cancer risk and progression. The primary outcome variable is metabolite identification and analysis. The secondary outcome variable is cancer risk as related to metabolites and genetic variants.
This study investigates the combination of an investigational medication, administered as telomelysin (OBP-301), with pembrolizumab in patients with advanced or metastatic gastric or gastroesophageal junction cancer. The purpose of this study is to determine if this combination is safe and effective for patients whose cancer has progressed despite previous treatments.Participants …
This study investigates the safety of using a type of immune cell therapy in patients with glioblastoma. The study will use T cells, which are a type of white blood cell, that have been modified to target specific proteins on cancer cells. These proteins are known as EGFR and IL13Ra2. …
This study investigates how effective one year versus two years of maintenance therapy is for patients with advanced ovarian cancer that has BRCA1/2 mutations or is homologous recombination deficient (HRD+). The purpose is to compare the effects of using the investigational medication, olaparib, with or without an antiangiogenic agent, bevacizumab, …
This study investigates the safety and effectiveness of an investigational medication in patients with relapsed or refractory leukemias, including those with specific genetic changes such as MLL/KMT2A gene rearrangement or NPM1 mutation. The study is divided into two phases: Phase 1 aims to find the best dose of the investigational …
This study investigates the effects of different maintenance therapies in people with newly diagnosed multiple myeloma. The purpose of this study is to compare the investigational medication teclistamab in combination with lenalidomide, teclistamab alone, and lenalidomide alone in maintaining health after a stem cell transplant.Participants will be randomly assigned to …
This study aims to prospectively compare the safety, effectiveness, and clinical utility of decongestive therapy administered by the Reprieve System to optimal diuretic therapy in adult ADHF patients presenting to the ED requiring decongestion. The Reprieve System continuously monitors urine output and urine sodium concentration to identify and administer the …
This study investigates the long-term safety and effects of an investigational medication in people with Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), or Non-Hodgkin Lymphoma (NHL) who have already received treatment. The purpose of this study is to provide participants from a previous study with the opportunity to continue …
Please choose between Voice or SMS based delivery of verification code
or